Log In
Print this Print this

Metformin DR (formerly NewMet)

  Manage Alerts
Collapse Summary General Information
Company Elcelyx Therapeutics Inc.
DescriptionDelayed-release, enteric-coated tablet formulation of metformin
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today